Antibe Therapeutics Inc(Pre-Merger) ATBPF

Let's be clear about DEAL/Partnership:

[cpac]

Magicbox and a couple others getting their panties in a twist about the talk around a deal on our lead drug. A few points to consider:
1) Management has always said they intended to partner after phase II.  All I said is that they are likely talking to big pharma now and I maintain that.  If you want a partnership, you don't wait until the day after you publish results to start those conversations.  It can be a long process, so you should be generating interest well before results are published.  
2) Trust me, big pharma needs small innovators biopharmas just as much as the other way around.  I have had the privilege to speak with mgmt of Merck, Pfizer and BMY over the years and their number 1 concern is usually 'the patent cliff' ... usually half their pipelines are in-licensed.  They just don't generate enough internally to offset maturing drugs.  
3)  Partnerships can and do happen at any time in the process.  Take a look at Turnstone Biologics which entered into a BILLION dollar deal with Takeda, even though the drug was preclinical.  Takeda partnered with them for the platform.  And yes, we also have a drug platform that applies not only to our lead drug, but potentially a whole portfolio behind that.

Cheers,
Cpac.